Vir Biotechnology (VIR) EBITDA (2018 - 2026)
Vir Biotechnology's EBITDA was $76.27 million in Q2 2026, compared with -$115.5 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) EBITDA (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vir Biotechnology's EBITDA was -$268.68 million through Jun 30, 2026; for FY2025, it came in at -$467.65 million.
- In earlier years, EBITDA was -$572.61 million in FY2024, -$664.32 million in FY2023, $840.38 million in FY2022 (+97.0%) and $426.58 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBITDA since Q3 2022.
- Per Business Quant data, VIR's EBITDA in the three quarters before Q2 2026 was -$129.48 million (Q1 2026), -$45.02 million (Q4 2025) and -$170.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.04 Bn | 1,100.62 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 614.86 Bn | 533.39 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.14 Bn | 321.52 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.69 Bn | 235.37 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.43 Bn | 191.82 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.90 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Vir Biotechnology | 1.82 Bn | -133.02 Mn | 238.95 Mn | 76.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.27 Mn |
| Mar 31, 2026 | -129.48 Mn |
| Dec 31, 2025 | -45.02 Mn |
| Sep 30, 2025 | -170.45 Mn |
| Jun 30, 2025 | -115.50 Mn |
| Mar 31, 2025 | -136.68 Mn |
| Dec 31, 2024 | -114.26 Mn |
| Sep 30, 2024 | -228.41 Mn |
| Jun 30, 2024 | -154.37 Mn |
| Mar 31, 2024 | -75.56 Mn |
| Dec 31, 2023 | -134.41 Mn |
| Sep 30, 2023 | -182.10 Mn |
| Jun 30, 2023 | -210.45 Mn |
| Mar 31, 2023 | -137.60 Mn |
| Dec 31, 2022 | -148.02 Mn |
| Sep 30, 2022 | 196.70 Mn |
| Jun 30, 2022 | -223.59 Mn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 573.29 Mn |
| Sep 30, 2021 | -51.85 Mn |
API Access
Vir Biotechnology EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();